Table 1 Participants’ demographic and clinical characteristics.
 | NSS group (n = 35) | SS group (n = 61) | p |
---|---|---|---|
Demographic characteristics | |||
 Gender (Male/Female) | 11/24 | 13/48 | 0.271 |
 Age | 26.46 ± 9.01 (16–44) | 25.52 ± 8.13 (16–45) | 0.604 |
 Education | 14.49 ± 2.25 (11–18) | 14.41 ± 2.15 (11–19) | 0.870 |
Clinical evaluations | |||
 BSSI | 0 | 53.10 ± 20.51 (15.15–93.94) | - |
 HAMD (exclude suicide item) | 21.03 ± 4.08 (11–29) | 24.89 ± 4.05 (16–33) | <0.001 |
 HAMA | 18.97 ± 8.53 (9–39) | 25.90 ± 8.56 (11–42) | <0.001 |
 MCCB total score | 46.59 ± 8.50 (28–61) | 44.93 ± 9.48 (20–64) | 0.432 |
 Duration of illness(years) | 3.67 ± 4.42 (0.08–20) | 4.03 ± 4.80 (0.08–21) | 0.716 |
Medication | |||
 Psychiatric medication (No/Yes) | 16/19 | 22/39 | 0.352 |
 Depression medication (No/Yes) | 11/24 | 17/44 | 0.712 |
 Mood stabilizers (No/Yes) | 19/16 | 23/38 | 0.115 |
Head motion | 0.081 ± 0.035 (0.033–0.174) | 0.089 ± 0.046 (0.028–0.238) | 0.420 |